Recombinant tissue-type plasminogen activator (rt-PA) treatment has been well established for ischaemic stroke therapy, but only a few ischaemic stroke patients can obtain benefits from rt-PA treatment because of the restrained therapeutic time window (Shi et al., 2015). Here, PLAT is linked to ischemic stroke.